Adaptive Biotechnologies ADPT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $77.58M+10.1% | $70.5M+28.1% | $55.03M+27.5% | $43.16M-14.8% | $50.65M+5.7% | ||
| $140.75M-10.1% | $156.49M-0.8% | $157.74M+2.0% | $154.71M+8.4% | $142.78M-18.1% | ||
| $48.32M-4.1% | $50.37M+12.4% | $44.82M+1.2% | $44.29M+1.6% | $43.58M+4.4% | ||
| $11.21M+14.1% | $9.82M-1.1% | $9.93M+18.2% | $8.4M-3.2% | $8.68M+2.9% | ||
| $291.81M-2.8% | $300.19M+6.7% | $281.44M+7.5% | $261.86M+2.1% | $256.49M-9.6% | ||
| $30.77M-9.8% | $34.11M-9.0% | $37.5M-8.7% | $41.06M-7.6% | $44.43M-8.6% | ||
| $118.97M0.0% | $118.97M0.0% | $118.97M0.0% | $118.97M0.0% | $118.97M0.0% | ||
| $1.31M-24.3% | $1.73M-19.9% | $2.16M-16.6% | $2.58M-14.1% | $3.01M-12.2% | ||
| $505.94M-1.3% | $512.74M+4.5% | $490.61M-1.2% | $496.64M-2.8% | $510.85M-5.3% | ||
| $9.62M+48.7% | $6.47M-37.0% | $10.27M+48.6% | $6.91M+8.6% | $6.36M-12.4% | ||
| $49.4M+9.3% | $45.19M+9.3% | $41.34M-25.3% | $55.3M+0.9% | $54.81M-1.6% | ||
| $5.8M+25.0% | $4.64M+91.1% | $2.43M-20.9% | $3.07M+52.7% | $2.01M+132% | ||
| $87.01M-3.2% | $89.92M+7.9% | $83.36M-9.5% | $92.14M+4.9% | $87.81M-10.4% | ||
| $124.75M-1.4% | $126.57M-2.2% | $129.41M-0.8% | $130.5M-0.8% | $131.55M-0.7% | ||
| $281.7M-2.1% | $287.74M+0.5% | $286.36M-9.7% | $317.1M-1.1% | $320.63M-4.8% | ||
| $16K+6.7% | $15K0.0% | $15K0.0% | $15K0.0% | $15K+7.1% | ||
| -$1.38B-1.5% | -$1.36B-1.0% | -$1.35B+0.7% | -$1.36B-1.9% | -$1.33B-2.3% | ||
| $216.34M-1.1% | $218.79M+7.0% | $204.44M+13.8% | $179.72M-5.6% | $190.42M-6.1% | ||
| $505.94M-1.3% | $512.74M+4.5% | $490.61M-1.2% | $496.64M-2.8% | $510.85M-5.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Adaptive Biotechnologies's total assets?
- Adaptive Biotechnologies (ADPT) holds $505.9M in total assets, down 1.0% year over year.
- How much debt does Adaptive Biotechnologies have?
- Adaptive Biotechnologies carries $208.2M in total debt against $216.3M of shareholders' equity, a debt-to-equity ratio of 0.96.
- How much cash does Adaptive Biotechnologies have?
- Adaptive Biotechnologies holds $77.6M in cash and equivalents.
- Can Adaptive Biotechnologies cover its short-term obligations?
- Its current ratio is 3.35 — current assets exceed current liabilities.
- Where does Adaptive Biotechnologies's balance sheet data come from?
- Every line is extracted from Adaptive Biotechnologies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
